Αποτελέσματα Αναζήτησης
Infant Botulism Treatment and Prevention Program provides clinical consultation and access to the specific antitoxin licensed for treatment of infant botulism.
7 Μαΐ 2021 · Treatment involves supportive care, intubation and mechanical ventilation when necessary, and administration of botulinum antitoxin. Certain neurological diseases (e.g., myasthenia gravis and Guillain-Barré syndrome) have signs and symptoms that overlap with botulism.
30 Απρ 2024 · These are the first comprehensive clinical care guidelines for botulism. They include: Best practices for diagnosing, monitoring, and treating botulism, including during outbreaks. Special considerations for infants, children, and people who are pregnant or breastfeeding.
15 Απρ 2022 · After this simulation learners should be able to: 1) develop a differential diagnosis for the hypotonic infant, 2) recognize signs and symptoms of infant botulism, 3) recognize respiratory failure and secure the airway with appropriate rapid sequence intubation (RSI) medications, 4) initiate definitive treatment of infant botulism by mobilizing ...
17 Οκτ 2024 · To characterize cases of outpatients with infant botulism (IB) in the United States (US) identified by the Infant Botulism Treatment and Prevention Program (IBTPP) at the California Department of Public Health (CDPH) from 1976 through 2021.
A specific treatment for infant botulism, intravenous botulism immunoglobulin (BIG-IV or BabyBIG®), was developed in 2003, and this treatment has substantially decreased both morbidity and hospital costs associated with this illness.
This article will review the pathogenesis of infant botulism as well as the epidemiology, clinical manifestations, diagnosis, and treatment of this condition. Keywords: botulism, infant, review, Clostridium, botulinum, infantile, paralysis.
